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Breast surgery is a common procedure performed in women. Many women who undergo breast surgery suffer from 
ill-defined pain syndromes. A nerve block is used in the treatment of the acute and chronic pain, but the effectiveness 
of the treatment has been limited because of its short duration. Recently, the advent of pulsed radiofrequency 
lesioning (PRF) has proved a successful treatment for chronic refractory pain involving the peripheral nerves. We 
experienced a case of a 52-year-old female patient complaining of chronic breast neuropathic pain after breast 
reduction, which was relieved after PRF lesioning of the 4th thoracic spinal nerve and its root. (Korean J Anesthesiol 
2010; 59: S238-S241)
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    Breast surgery is commonly performed in women, and the 
frequency of this surgery has increased. Breast surgery is divided 
into four types, mastectomy, mastectomy with reconstruction, 
breast augmentation and breast reduction, depending on the 
cause and treatment. Many patients complain of postoperative 
pain, and some of them complain of continuous, chronic pain.
    A nerve block with local anesthetics is performed as a 
diagnostic and therapeutic block. This strategy is known to be 
effective in reducing pain. When the nerve that is responsible 
for the pain is identified by a nerve block, the effect can be 
extended by applying physical methods such as neurolytics or 
radiofrequency thermocoagulation. Recently, the strategy of 
pulsed radiofrequency lesioning (PRF) has become common 
for pain control in the peripheral nerve region. This procedure 
is not associated with side effects such as nerve destruction or 
pain [1].
    Herein, we report our experience with pain relief via an 
application of PRF to the 4th thoracic spinal nerve and its root 
in a patient who complained of the chronic postoperative pain 
at the operation site after breast reduction.
Case Report
    A 52-year-old female patient visited the hospital complaining 
of pain in both breasts. The pain started immediately after 
breast reduction surgery she underwent 3 years previously at a S239 www.ekja.org
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private plastic surgery hospital, and it had continued despite a 
subsequent surgery. The pattern of the pain included burning, 
shooting and itching sensations at the operation site as well 
as unbearable burning sensations when the patient was in 
the places where the temperature was higher than normal. 
The pain as measured by the visual analogue scale (VAS) was 
approximately 70/100 mm. In particular, the degree of pain 
was dependent on the season, and it was unbearable under 
hot weather, with the patient complaining of pain at VAS 80-
90/100 mm. Before coming to the hospital, the patient had 
taken aceclofenac (Airtal
Ⓡ, Daewoong Pharmaceutical) 200 mg, 
pregabalin (Lyrica
Ⓡ, Pfizer) 300 mg, acetaminophen 1,300 mg 
and tramadol HCl 150 mg (Ultracet
Ⓡ, Janssen Korea) per day, 
but the pain was not relieved. Thus, the patient tried pregabalin 
600 mg, acetaminophen 1,300 mg and tramadol HCl 150 mg 
per day, but there was no effect. Complaining of dizziness due 
to Ultracet
Ⓡ, the patient started to take 20 mg of oxycodone 
HCl (Oxycontin
Ⓡ, Mundipharma Korea) each day, but she 
eventually stopped taking it because of dizziness, nausea, and 
vomiting. Subsequently, the patient underwent drug treatment 
with pregabalin 300 mg a day, but she visited the hospital 
because the pain did not subside.
    There was no specific finding in a simple plane chest X-ray 
spectrograph, while digital infrared thermographic imaging 
(DITI) showed a slight temperature drop in both breasts. The 
past and family histories of the patient were non-specific.
    Because the previous treatments were not effective in impro-
ving the symptoms and because the patient wanted another 
method of treatment due to the continued pain, it was decided 
that a thoracic epidural block would be performed, and 
informed consent was obtained from the patient. The patient 
was laid on her side and the epidural space was checked using 
the loss-of-resistance method with a 22-gauge epidural needle 
(Hakko, Japan) in between the T4 and T5, applying an aseptic 
technique in the interlaminar approach. 0.5% mepivacaine HCl 
(emcaine 2% inj.
Ⓡ Reyon Pharm) 6 ml was then injected. The 
pain was relieved into the VAS range of 40-50/100 mm after 
the procedure, and the patient was discharged. The VAS was 
decreased to 40-50/100 mm after an additional procedure a 
week later, but the patient complained of continued pain. A 
decision was made to carry out PRF to the spinal nerve and 
its root and. To measure the level and determine the effect, 
informed consent was received from the patient after she was 
provided with an explanation of the procedure and the side 
effects that may occur after the procedure. For the diagnosis, 
selective nerve root block (SNB) was performed at T3, T4 and 
T5, one level each time in order with an interval of 2 days, 
by injecting 1% lidocaine 0.5 ml with a 25-gauge Quincke 
needle (Spinocan
Ⓡ, B│BRAUN). Pain relief in the patient was 
confirmed after SNB at T4. PRF was carried out at the fourth 
thoracic spinal nerve and its root after giving an explanation 
to the patient about the procedure and the side effects that 
may occur after the procedure and receiving informed consent 
once again. After supporting the patient’s lower abdomen with 
a pillow and placing her in a prone position, the site of the 
procedure was disinfected by a common sterilizing method 
and a standard monitor was attached. The area between T4 and 
T5 was identified in the anteroposterior view using a C-arm 
device and the 4 cm point right lateral from the T4 spinous 
process was chosen as the needle implantation point. Local 
anesthesia was carried out with 1% lidocaine, and a 20-gauge 10 
cm long RF cannula (OWL sharp curved RF insulated cannula, 
Diros Technology Inc., USA) with a 10 mm-active tip was 
then introduced into the anesthetized part. By continuously 
monitoring the position of the cannula with the C-arm, 
it continued to the inferior of end plate of fourth thoracic 
vertebral body (Fig. 1), and the tip of the cannula was located at 
the posterior border of the vertebral space in the lateral view 
(Fig. 2). Contrast material was injected to check the epidurogram 
and radiculogram (Fig. 3), and an RF generator (RFG-3C plus, 
Radionics, USA) was then connected and an electric stimulus of 
50 Hz at 0.1 volt was applied. The electric stimulus was sensed 
at the T4 dermatome. Following this, electric stimulus of 2 
Hz at 0.1 volt was applied, and it was verified that the muscle 
did not contract up to 0.8 volt. One minute after injecting 
1% mepivacaine 1 ml, PRF was performed two times for 120 
seconds at 42
oC. The same procedure was performed on the 
opposite side after one week. During the procedure, the vital 
signs of the patient were normal and no side effect took place. 
After the procedure, the pain was reduced to VAS 20-30/100 
mm. The patient currently undergoes oral administration of 
Fig. 1. Fluoroscopic image of the anteroposterior view shows the 
introducer needle. S240 www.ekja.org
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pregabalin 300 mg/day and nortriptyline (Sensival
Ⓡ, Ilsung 
Pharm) 10 mg/day and this was followed up at the hospital for 9 
months without particular exacerbation of the pain or any other 
inconvenience in her daily tasks.
Discussion
    Pain after breast surgery, which is commonly complaint 
by patients, is known to be related with the injury, ischemia 
and inflammation of the soft tissue. If the pain in the affected 
part and arm continues for one year after the surgery, it is 
considered as chronic pain in general [2]. The mechanism is 
not yet accurately known, but the chronic pain may be caused 
by injuries in various peripheral nerves that arise during 
the surgery and can develop into neuropathic pain such as 
stabbing, pricking, burning, shooting and sharp pains [2,3]. 
Neuropathic pain can be caused by any type of breast surgery 
[4]. Wallace et al. [3] investigated 282 women who underwent 
different types of breast surgery, and their result showed that 
31% of women who underwent mastectomy, 49% of those who 
underwent mastectomy with reconstruction, 38% of those 
who underwent cosmetic augmentation and 22% of those 
who underwent breast reduction complained of pain up to 
one year after the surgery. Particularly, as the survival rate of 
breast cancer patients has increased, the number of patients 
who complain of chronic pain after breast cancer survey has 
also increased [2]. Nonetheless, many patients are not given an 
appropriate pain treatment [4].
    The patient in this case study was also a chronic neuropathic 
pain patient whose pain had continued for 3 years following 
breast reduction surgery. She complained of pricking, shooting 
and burning sensations at the site of the operation. Although 
the patient complained of pain immediately after the surgery, 
she continued to suffer neuropathic pain for 3 years without 
being given appropriate pain treatment because she was not 
able to take medicine due to the side effects of the drugs.
    Macrae [5] stated that severe acute pain after the surgery may 
be a risk factor for chronic pain. This can be one possible cause 
of the chronic pain of the patient in this case report, because she 
complained severe pain at VAS 70-80/100 mm immediately 
after the surgery but the pain was not properly controlled.
    In general, it is thought that the intercostal nerve (ICN) from 
T1 to T6 and the nerves that originate from those braches can 
be damaged by breast surgery [2]. For the patient in this case 
report, because she complained of the pain at the dermatome 
of the T4 spinal nerve, neuropathic pain caused by damage at 
the 4th ICN and at the branch was suspected.
    The effect of a nerve block in controlling pain after breast 
surgery is well known. In particular, it was reported that a 
paravertebral block (PVB) reduced pain, nausea and vomiting 
after breast surgery [6]. In addition, Kairaluoma et al. [7] 
reported that preoperative PVB reduced chronic pain after 
breast surgery. These results show that a nerve block can be 
used in controlling pain following breast surgery effectively, 
preventing it from becoming chronic.
    A nerve block using a local anesthetic is easy to perform in the 
treatment of pain and is effective in reducing pain. However, 
because the duration of desensibilization may not be sufficient 
depending on the disease causing the pain and because 
many repeated procedures may be required, radiofrequency 
thermocoagulation is sometimes employed to maintain the 
effect of the nerve block. Radiofrequency thermocoagulation 
Fig. 2. Fluoroscopic image of the lateral view before contrast dye was 
injected.
Fig. 3. Fluoroscopic image of the lateral view after contrast dye was 
injected.S241 www.ekja.org
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was first introduced in 1930’s by Kirschner, who applied it 
treating trigeminal neuralgia at the Gasserian ganglion [8]. 
Recently, the application of radiofrequency thermocoagulation 
in the case of various diseases has gradually increased as quality 
of the radiofrequency generator, the associated equipment, and 
the catheter needle has been improved. This treatment is highly 
advantageous, in that a more accurate lesion can be generated 
compared to other nerve-destructive procedures. Moreover, the 
resistance and temperature can be continuously monitored to 
minimize the side effects. The mechanism of radiofrequency 
thermocoagulation is known to change the nerve tissue due to 
the heat around the electrode, blocking and the inflow of the 
nerve stimulus. On the other hand, PRF was introduced as a 
new method because another mechanism of radiofrequency-
aided treatment arises in that a clinical effect is noted by the 
heat applied to the nerve and the electromagnetic field that 
forms around the electrode.
    PRF is a radiofrequency-aided treatment in which pulsed 
radiofrequency stimulus of 20 msec is generated two times 
every 0.5 second at a temperature of 42
oC, which is low enough 
for the nerve tissue to remain undamaged. PRF is a novel 
treatment method that has corrected the problems of previous 
radiofrequency-aided treatments based on heat. It does not 
cause nerve destruction, side effects such as neuritis, or the 
complications of other types of radiofrequency-aided treat-
ments based on heat. It can be performed to treat neuropathic 
pain even for body parts where side effects take place frequently 
due to radiofrequency thermocoagulation. It can be also 
performed on parts near bone or scar tissue, where the risk of 
complications is high when radiofrequency thermocoagulation 
is performed [9]. Rohof [1] applied PRF to the suprascapular 
nerve in the treatment of chronic shoulder pain and reported 
it to be a novel treatment method that is free from side 
effects or complications, in contrast to the conventional 
thermocoagulation. Moreover, positive effects were reported 
when PRF was applied to peripheral nerves such as the 
facial nerve, superior laryngeal nerve, suprascapular nerve, 
intercostals nerve, obturator nerve and the joint-dominating 
peripheral nerve articular branch, whose main nerve is sensory. 
In this case report as well, although the pain was controlled by 
an epidural block with a local anesthetic, repeated procedures 
were required due to the short duration of the first treatment. 
Long-lasting pain reduction was achieved without any specific 
side effect, as the PRF was carried out on the spinal nerve and 
its root under monitoring by a C-arm device. 
    In this article, we report a case in which PRF was applied to 
control the pain of a patient who came to the hospital com-
plaining of chronic severe neuropathic pain at the operation 
site that arose after breast reduction surgery. Appropriate 
pain control after breast surgery can reduce the suffering of 
the patient due to early pain and greatly affect the quality of 
life of the patient by preventing the pain from being chronic. 
If an appropriate pain treatment had been given after breast 
surgery to the patient in this case report, she would have not 
suffered from chronic pain. In the case of breast surgery, 
considerable attention should be paid to postoperative pain 
as well as surgical pain, and pain treatment should be carried 
out positively. It is thought that a nerve block as well as general 
analgesics can be helpful as a pain control strategy. In addition, 
PRF may be helpful in reducing the pain of the patients who 
are not responsive to a nerve block using analgesics or local 
anesthetics. Furthermore, additional studies are needed 
regarding the reduction of chronic neuropathic pain by PRF 
after breast surgery.
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